Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Radiotherapy for head and neck cancer.

D L Schwartz1, A S Garden

  • 1Department of Radiation Oncology, M.D. Anderson Cancer Center, Unit 97, 1515 Holcombe Boulevard, Houston, TX 77030, USA. docdls@mdanderson.org

Hematology/Oncology Clinics of North America
|May 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Initial Impact and Operational Response of Radiation Oncology Practices to the COVID-19 Pandemic in the United States, Europe, and Latin America.

International journal of radiation oncology, biology, physics·2021
Same author

Characterization of MR Imaging-Visible Perivascular Spaces in the White Matter of Healthy Adolescents at 3T.

AJNR. American journal of neuroradiology·2020
Same author

Interactive website for head and neck cancer patients: Adherence and coping program to prevent dysphagia after radiation.

Internet interventions·2020
Same author

Weekly paclitaxel, carboplatin, cetuximab, and cetuximab, docetaxel, cisplatin, and fluorouracil, followed by local therapy in previously untreated, locally advanced head and neck squamous cell carcinoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Chemoradiation in anaplastic thyroid carcinomas.

Critical reviews in oncology/hematology·2012
Same author

Sonographic examination of the neck after definitive radiotherapy for node-positive oropharyngeal cancer.

AJNR. American journal of neuroradiology·2011
Same journal

Palliative Therapy for Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Ablative Therapies for Liver Tumors.

Hematology/oncology clinics of North America·2026
Same journal

Pathology of Liver and Biliary Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Minimally Invasive Surgery for Liver and Biliary Tract Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Surgical Considerations for Primary Liver Neoplasms.

Hematology/oncology clinics of North America·2026
Same journal

Systemic Therapy for Biliary and Liver Neoplasms: Chemotherapy and Immunotherapy.

Hematology/oncology clinics of North America·2026
See all related articles

Head and neck cancer survivorship is improving due to advances in radiotherapy, chemotherapy, and surgical techniques. Future progress in biologic therapy and imaging promises even better outcomes for patients.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Head and Neck Surgery

Background:

  • Head and neck cancer survivorship has historically faced challenges.
  • Radiotherapy has been a cornerstone in improving patient outcomes.
  • Multidisciplinary management is crucial for solid tumor success.

Purpose of the Study:

  • To review the advancements in head and neck cancer radiotherapy.
  • To discuss the evolving landscape of cancer survivorship.
  • To highlight future directions in treatment and rehabilitation.

Main Methods:

  • Review of current and emerging radiotherapy technologies.
  • Analysis of radiosensitizing chemotherapy and biologic therapies.
  • Integration of surgical techniques, functional imaging, and rehabilitation.

Related Experiment Videos

Main Results:

  • Significant improvements in the length and quality of head and neck cancer survivorship.
  • Radiotherapy advances have been central to these improvements.
  • Emerging strategies show promise for continued progress.

Conclusions:

  • Head and neck cancer management is transitioning from a disease of failure to a success story.
  • Continued dedication from providers and patients is essential.
  • Future innovations in therapy and rehabilitation will further enhance survivorship.